| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |